Ophiomics is now participating in the IPOready program by Euronext. This is a great opportunity to consider the best strategy to achieve our ambition to have a global impact in the world of Cancer Precision Medicine
Related Posts
October marked Liver Cancer Awareness Month, a time to spotlight one of the world’s fastest-growing and deadliest cancers: Over 900,000
Ophiomics is heading to Riyadh! We will be attending and exhibiting at the Global Health Exhibition, taking place 27–30 October.
Precision in IVD Tools: How Machine Learning Elevates HepatoDetect for Early HCC Detection Early detection of hepatocellular carcinoma (HCC) in
The most innovative diagnostic test is of little value if it cannot be implemented efficiently in real-world clinical settings. Current
+351 211 369 829 